1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Veterinary Vaccines Global Market Outlook - Trends, Forecast, and Opportunity Assessment (2014-2022)

The Global Veterinary Vaccines Market accounted for $5.3 billion in 2014 and is expected to grow at a CAGR of 6.2% to reach $8.6 billion by 2022. The factors driving the veterinary vaccines market include rising zoonotic diseases, growing incidence of animal diseases, increasing investments by government and welfare associations. However, factors such as increasing adoption of vegetarian food in prominent economies and increasing costs of storage and maintenance of vaccines are hindering the market growth. Growing awareness of animal health in emerging economies and technological innovations are likely to create opportunities for veterinary vaccines market in the coming years.

The Global veterinary vaccines market is segmented on the basis of diseases, technologies and geography. On the basis of diseases, the veterinary vaccine market is segmented into companion animal diseases (respiratory, gastrointestinal and reproductive tracts), poultry diseases (bronchitis, avian influenza, newcastle disease and marek's disease), porcine diseases (porcine reproductive disease, swine pneumonia and swine influenza) and equine diseases (rhinopneumonitis, influenza and encephalomyelitis). By technologies, the market is categorized into toxoid vaccines, DNA vaccines, recombinant vaccines, live attenuated vaccines (LAV) and inactivated vaccines. By geography, it is segmented into North America, Europe, Asia Pacific and Rest of the World. European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S. However, Asia is expected to register a higher growth rate during the forecast period owing to huge investment opportunities in this region.

Some of the key players in the veterinary vaccine market include Zoetis (U.S.), Merck Animal Health (U.S.), Merial Inc. (Sanofi) (France), Elanco Animal Health (U.S.)., Boehringer Ingelheim (Germany), Bayer Healthcare (Germany), Bioniche Animal Health (Canada), Heska Co. (U.S.), Ceva Animal Health, Inc. and Virbac.

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Table Of Contents

Veterinary Vaccines Global Market Outlook - Trends, Forecast, and Opportunity Assessment (2014-2022)
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Veterinary Vaccines Market, By Diseases
5.1 Introduction
5.2 Companion animal diseases
5.2.1 Respiratory diseases
5.2.2 Gastrointestinal diseases
5.2.3 Reproductive diseases
5.3 Poultry diseases
5.3.1 Bronchitis
5.3.2 Avian influenza
5.3.3 Newcastle disease
5.3.4 Marek's disease
5.4 Porcine diseases
5.4.1 Porcine reproductive disease
5.4.2 Swine pneumonia
5.4.3 Swine influenza
5.5 Equine diseases
5.5.1 Rhinopneumonitis
5.5.2 Influenza
5.5.3 Encephalomyelitis

6 Global Veterinary Vaccines Market, By Technologies
6.1 Introduction
6.2 Toxoid vaccines
6.3 DNA vaccines
6.4 Recombinant vaccines
6.5 Live attenuated vaccines
6.6 Inactivated vaccines

7 Global Veterinary Vaccines Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia
7.4 Rest of the World
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions and Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Zoetis (U.S.)
9.2 Merck Animal Health (U.S.)
9.3 Merial Inc. (Sanofi) (France)
9.4 Elanco Animal Health (U.S.).
9.5 Boehringer Ingelheim (Germany)
9.6 Bayer Healthcare (Germany)
9.7 Bioniche Animal Health (Canada)
9.8 Heska Co. (U.S.)
9.9 Ceva Animal Health, Inc.
9.10 Virbac

List of Tables
1 Global Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN)
2 Global Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN)
3 Global Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN)
4 Global Veterinary Vaccines Market Outlook, By Gastrointestinal diseases (2012-2022) ($MN)
5 Global Veterinary Vaccines Market Outlook, By Reproductive diseases (2012-2022) ($MN)
6 Global Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN)
7 Global Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN)
8 Global Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN)
9 Global Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN)
10 Global Veterinary Vaccines Market Outlook, By Marek's disease (2012-2022) ($MN)
11 Global Veterinary Vaccines Market Outlook, By Porcine diseases (2012-2022) ($MN)
12 Global Veterinary Vaccines Market Outlook, By Porcine reproductive disease (2012-2022) ($MN)
13 Global Veterinary Vaccines Market Outlook, By Swine pneumonia (2012-2022) ($MN)
14 Global Veterinary Vaccines Market Outlook, By Swine influenza (2012-2022) ($MN)
15 Global Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN)
16 Global Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN)
17 Global Veterinary Vaccines Market Outlook, By Influenza (2012-2022) ($MN)
18 Global Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN)
19 Global Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN)
20 Global Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN)
21 Global Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN)
22 Global Veterinary Vaccines Market Outlook, By Recombinant vaccines (2012-2022) ($MN)
23 Global Veterinary Vaccines Market Outlook, By Live attenuated vaccines (2012-2022) ($MN)
24 Global Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN)
25 North America Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN)
26 North America Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN)
27 North America Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN)
28 North America Veterinary Vaccines Market Outlook, By Gastrointestinal diseases (2012-2022) ($MN)
29 North America Veterinary Vaccines Market Outlook, By Reproductive diseases (2012-2022) ($MN)
30 North America Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN)
31 North America Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN)
32 North America Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN)
33 North America Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN)
34 North America Veterinary Vaccines Market Outlook, By Marek's disease (2012-2022) ($MN)
35 North America Veterinary Vaccines Market Outlook, By Porcine diseases (2012-2022) ($MN)
36 North America Veterinary Vaccines Market Outlook, By Porcine reproductive disease (2012-2022) ($MN)
37 North America Veterinary Vaccines Market Outlook, By Swine pneumonia (2012-2022) ($MN)
38 North America Veterinary Vaccines Market Outlook, By Swine influenza (2012-2022) ($MN)
39 North America Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN)
40 North America Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN)
41 North America Veterinary Vaccines Market Outlook, By Influenza (2012-2022) ($MN)
42 North America Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN)
43 North America Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN)
44 North America Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN)
45 North America Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN)
46 North America Veterinary Vaccines Market Outlook, By Recombinant vaccines (2012-2022) ($MN)
47 North America Veterinary Vaccines Market Outlook, By Live attenuated vaccines (2012-2022) ($MN)
48 North America Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN)
49 Europe Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN)
50 Europe Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN)
51 Europe Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN)
52 Europe Veterinary Vaccines Market Outlook, By Gastrointestinal diseases (2012-2022) ($MN)
53 Europe Veterinary Vaccines Market Outlook, By Reproductive diseases (2012-2022) ($MN)
54 Europe Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN)
55 Europe Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN)
56 Europe Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN)
57 Europe Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN)
58 Europe Veterinary Vaccines Market Outlook, By Marek's disease (2012-2022) ($MN)
59 Europe Veterinary Vaccines Market Outlook, By Porcine diseases (2012-2022) ($MN)
60 Europe Veterinary Vaccines Market Outlook, By Porcine reproductive disease (2012-2022) ($MN)
61 Europe Veterinary Vaccines Market Outlook, By Swine pneumonia (2012-2022) ($MN)
62 Europe Veterinary Vaccines Market Outlook, By Swine influenza (2012-2022) ($MN)
63 Europe Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN)
64 Europe Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN)
65 Europe Veterinary Vaccines Market Outlook, By Influenza (2012-2022) ($MN)
66 Europe Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN)
67 Europe Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN)
68 Europe Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN)
69 Europe Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN)
70 Europe Veterinary Vaccines Market Outlook, By Recombinant vaccines (2012-2022) ($MN)
71 Europe Veterinary Vaccines Market Outlook, By Live attenuated vaccines (2012-2022) ($MN)
72 Europe Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN)
73 Asia Pacific Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN)
74 Asia Pacific Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN)
75 Asia Pacific Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN)
76 Asia Pacific Veterinary Vaccines Market Outlook, By Gastrointestinal diseases (2012-2022) ($MN)
77 Asia Pacific Veterinary Vaccines Market Outlook, By Reproductive diseases (2012-2022) ($MN)
78 Asia Pacific Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN)
79 Asia Pacific Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN)
80 Asia Pacific Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN)
81 Asia Pacific Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN)
82 Asia Pacific Veterinary Vaccines Market Outlook, By Marek's disease (2012-2022) ($MN)
83 Asia Pacific Veterinary Vaccines Market Outlook, By Porcine diseases (2012-2022) ($MN)
84 Asia Pacific Veterinary Vaccines Market Outlook, By Porcine reproductive disease (2012-2022) ($MN)
85 Asia Pacific Veterinary Vaccines Market Outlook, By Swine pneumonia (2012-2022) ($MN)
86 Asia Pacific Veterinary Vaccines Market Outlook, By Swine influenza (2012-2022) ($MN)
87 Asia Pacific Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN)
88 Asia Pacific Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN)
89 Asia Pacific Veterinary Vaccines Market Outlook, By Influenza (2012-2022) ($MN)
90 Asia Pacific Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN)
91 Asia Pacific Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN)
92 Asia Pacific Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN)
93 Asia Pacific Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN)
94 Asia Pacific Veterinary Vaccines Market Outlook, By Recombinant vaccines (2012-2022) ($MN)
95 Asia Pacific Veterinary Vaccines Market Outlook, By Live attenuated vaccines (2012-2022) ($MN)
96 Asia Pacific Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN)
97 Rest Of The World Veterinary Vaccines Market Outlook, By Diseases (2012-2022) ($MN)
98 Rest Of The World Veterinary Vaccines Market Outlook, By Companion animal diseases (2012-2022) ($MN)
99 Rest Of The World Veterinary Vaccines Market Outlook, By Respiratory diseases (2012-2022) ($MN)
100 Rest Of The World Veterinary Vaccines Market Outlook, By Gastrointestinal diseases (2012-2022) ($MN)
101 Rest Of The World Veterinary Vaccines Market Outlook, By Reproductive diseases (2012-2022) ($MN)
102 Rest Of The World Veterinary Vaccines Market Outlook, By Poultry diseases (2012-2022) ($MN)
103 Rest Of The World Veterinary Vaccines Market Outlook, By Bronchitis (2012-2022) ($MN)
104 Rest Of The World Veterinary Vaccines Market Outlook, By Avian influenza (2012-2022) ($MN)
105 Rest Of The World Veterinary Vaccines Market Outlook, By Newcastle disease (2012-2022) ($MN)
106 Rest Of The World Veterinary Vaccines Market Outlook, By Marek's disease (2012-2022) ($MN)
107 Rest Of The World Veterinary Vaccines Market Outlook, By Porcine diseases (2012-2022) ($MN)
108 Rest Of The World Veterinary Vaccines Market Outlook, By Porcine reproductive disease (2012-2022) ($MN)
109 Rest Of The World Veterinary Vaccines Market Outlook, By Swine pneumonia (2012-2022) ($MN)
110 Rest Of The World Veterinary Vaccines Market Outlook, By Swine influenza (2012-2022) ($MN)
111 Rest Of The World Veterinary Vaccines Market Outlook, By Equine diseases (2012-2022) ($MN)
112 Rest Of The World Veterinary Vaccines Market Outlook, By Rhinopneumonitis (2012-2022) ($MN)
113 Rest Of The World Veterinary Vaccines Market Outlook, By Influenza (2012-2022) ($MN)
114 Rest Of The World Veterinary Vaccines Market Outlook, By Encephalomyelitis (2012-2022) ($MN)
115 Rest Of The World Veterinary Vaccines Market Outlook, By Technologies (2012-2022) ($MN)
116 Rest Of The World Veterinary Vaccines Market Outlook, By Toxoid vaccines (2012-2022) ($MN)
117 Rest Of The World Veterinary Vaccines Market Outlook, By DNA vaccines (2012-2022) ($MN)
118 Rest Of The World Veterinary Vaccines Market Outlook, By Recombinant vaccines (2012-2022) ($MN)
119 Rest Of The World Veterinary Vaccines Market Outlook, By Live attenuated vaccines (2012-2022) ($MN)
120 Rest Of The World Veterinary Vaccines Market Outlook, By Inactivated vaccines (2012-2022) ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.